If you are diabetic, be better aware of this. Currently, the diagnosis of diabetes mellitus worldwide is gradually increasing, and a new study published in The Lancet warns that if this increase in patients continues, it will not be enough insulin for all
According to the Mexican Diabetes Federation insulin is a hormone produced by beta-pancreatic cells in response to elevated blood glucose levels. Therefore, the insulin substance is produced in the body to help with energy consumption, so all daily activities can be carried out.
However, in some cases, the pancreas does not produce enough insulin or can not properly use it in the body, so it should be listed outside the syringe.
A warning for the global deficit
In this regard, a study conducted by researchers at Stanford University in the United States and published in The Lancet says that if the trend of increased sugar continues, insulin will be enough.
According to researchers, half of people with a disease need insulin, but can not access it. Researchers at Stanford University also explain that more than a decrease in diabetes has increased, and access to insulin is increasingly complicated as prices have increased significantly.
Costs and availability of insulin
In this regard, a study published in JAMA showed that the price of insulin increased three times between 2002 and 2013, although production costs remained unchanged. In Mexico, the National Institute of Public Health (INSP) has recently revealed that diabetes is the leading cause of death in Mexico; 14% of adults in Mexico have diabetes and it is estimated that there could be 80,000 deaths annually.
Finally, data from the International Diabetes Association show that prevalence of type 2 diabetes will increase between 2018 and 2030.